Increasing evidence supports the role of Toll-like receptors (TLRs) in inducing neuroinflammation in various NDs, including PD, particularly TLR2 (Fiebich et al., 2018; Heidari et al., 2022). This evidence concerns the gene TLR2 and Parkinson disease.